Panel Discussion: iRAE Sessions and Studies
      4 years 11 months ago

      Panelists Dr. David Liew, Dr. Laura Cappelli, Dr. Cassandra Calabrese and Dr. Karmela Kim Chan discuss iRAE sessions and studies presented at the 2020 ACR annual meeting. 

      How FAST can you go? Dr. Michael Pillinger
      4 years 11 months ago

      Dr. Pillinger weighs in with his view of the FAST trial (abstract L08) presented at ACR 2020.

      Cardiovascular Safety for Feboxustat with Dr. Nicola Dalbeth
      4 years 11 months ago

      Auckland's Dr. Dalbeth examines the cardiovascular safety in the FAST trial of feboxustat (abstract L08) presented at the ACR 2020.

      The axSpa diagnosis, imaging and treatments: Dr. Lianne Gensler
      4 years 11 months ago

      Dr. Lianne Gensler reviews several SpA abstracts and a session on MRI presented at the 2020 ACR annual meeting. Abstracts reviews: abstract #1883, #2014, #L11 and #2022. 

       

      Adverse Events in Low-Dose Methotexate: Dr. Eric Dein
      4 years 11 months ago

      Dr. Eric Dein reviews abstract #2001 presented at the 2020 ACR annual meeting. 

      Pregnancy Outcomes in Lupus and SpA: Dr. Kathryn Dao
      4 years 11 months ago

      Dr. Dao reviews abstracts #1770, #1771 and #1762 presented at the 2020 ACR annual meeting. 

      Dr. Tom Appleton and Dr. Peter Nash Highlight OA and PsA Studies
      4 years 11 months ago

      Dr. Janet Pope interviews Dr. Tom Appleton and Dr. Peter Nash about several osteoarthritis and psoriatic arthritis studies presented at the 2020 ACR annual meeting.

      RT @RHEUMarampa: TAK & GCA differ in vessel involvement when it comes to the 👁👁
      > TAK- large vessel lesions

      sheila RHEUMarampa

      4 years 11 months ago
      TAK & GCA differ in vessel involvement when it comes to the 👁👁 > TAK- large vessel lesions > GCA- small vessel vasculitis @RheumNow #ACR20 https://t.co/sa4VEvCKOt
      RT @synovialjoints: I would usually be on a Transatlantic flight at this point post-ACR. Going #virtual is great as I ne

      Dr. Antoni Chan synovialjoints

      4 years 11 months ago
      I would usually be on a Transatlantic flight at this point post-ACR. Going #virtual is great as I never left. What did you miss most about a face to face conference? @RheumNow #ACR20
      RT @KDAO2011: Dr. Cush and Dr. Kavanaugh recaps the #ACR20 meeting during #RheumatologyRoundUp highlighting important st

      k dao KDAO2011

      4 years 11 months ago
      Dr. Cush and Dr. Kavanaugh recaps the #ACR20 meeting during #RheumatologyRoundUp highlighting important studies that were presented during the mtg and how they might impact practices. Log into https://t.co/3hCmtuN7kj to view this and all our videos/news stories. @RheumNow https://t.co/HgiA1QrdIX
      RT @RHEUMarampa: IgG4-RD tx: GCs are mainstay tx starting at 30-40mg/d tapered gradually but 30% of pts will have recurr

      sheila RHEUMarampa

      4 years 11 months ago
      IgG4-RD tx: GCs are mainstay tx starting at 30-40mg/d tapered gradually but 30% of pts will have recurrences Potential therapeutic targets to ⬇GC toxicity ✏B cell/plasmablasts (promising) ✏T cells (anecdotal) @RheumNow #ACR20 https://t.co/X2NI3vFUgl
      RT @uptoTate: Somatic mutation (in UBA1) may account for a significant fraction of adult-onset inflammatory disease” says Dr. Dan Kastner. Have you seen VEXAS in your clinic? #ACR20 @RheumNow

      Dr. Rachel Tate uptoTate

      4 years 11 months ago

      ”Somatic mutation (in UBA1) may account for a significant fraction of adult-onset inflammatory disease” says Dr. Dan Kastner. Have you seen VEXAS in your clinic? #ACR20

      @RheumNow

      physical therapy
      Systemic Sclerosis and Physical Therapy
      4 years 11 months ago
      Systemic sclerosis (SSc) is a chronic fibrosing disease currently with no available cure. Just as pharmacologic treatment is important to control the disease or delay its progression, non-pharmacologic interventions are also essential in the management of patients. 
      RT @DrMiniDey: Reflecting on my first @ACRheum Congress- it wasn’t how I expected my first ACR to be. But #ACR20 was b

      Mrinalini Dey DrMiniDey

      4 years 11 months ago
      Reflecting on my first @ACRheum Congress- it wasn’t how I expected my first ACR to be. But #ACR20 was brilliant given the circumstances! Easily one of the best virtual events I’ve attended- smooth platform, huge variety of sessions and efficient on-demand service. @RheumNow
      RT @Janetbirdope: Spot diagnosis @RheumNow @CRASCRRheum #ACR20 hint this woman has 2 rheumatic diseases https://t.co/kEu

      Janet Pope Janetbirdope

      4 years 11 months ago
      Spot diagnosis @RheumNow @CRASCRRheum #ACR20 hint this woman has 2 rheumatic diseases https://t.co/kEu9COJY3B

      Catch up on Conference Podcasts

      ×